Meditation awareness training for the treatment of fibromyalgia syndrome: A randomized controlled trial.
Study Goal
The researchers aimed to evaluate the effectiveness of a second-generation mindfulness-based intervention (SG-MBI) called meditation awareness training (MAT) for treating fibromyalgia syndrome (FMS) compared to an active control group.
Results Summary
MAT participants showed significant and sustained improvements in FMS symptoms, pain perception, sleep quality, psychological distress, non-attachment, and civic engagement compared to the control group. Non-attachment and civic engagement mediated treatment effects, and daily meditation time predicted positive changes in all outcomes.
Population
Adults with fibromyalgia syndrome (FMS).
Effective Dosage
Not specified (8-week program, daily meditation time was a predictor but exact frequency/duration not detailed).
Duration
8 weeks, with follow-up assessments at post-intervention and 6 months.
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Meditation awareness training (MAT) | decrease | FMS symptomatology | Adults with FMS | - | demonstrated significant and sustained improvements | #1 |
Meditation awareness training (MAT) | decrease | pain perception | Adults with FMS | - | demonstrated significant and sustained improvements | #2 |
Meditation awareness training (MAT) | increase | sleep quality | Adults with FMS | - | demonstrated significant and sustained improvements | #3 |
Meditation awareness training (MAT) | decrease | psychological distress | Adults with FMS | - | demonstrated significant and sustained improvements | #4 |
Meditation awareness training (MAT) | increase | non-attachment (to self, symptoms, and environment) | Adults with FMS | - | demonstrated significant and sustained improvements | #5 |
Meditation awareness training (MAT) | increase | civic engagement | Adults with FMS | - | demonstrated significant and sustained improvements | #6 |
Meditation awareness training (MAT) | neutral | all outcome variables | Adults with FMS | - | civic engagement partially mediated treatment effects | #7 |
Meditation awareness training (MAT) | neutral | psychological distress | Adults with FMS | - | non-attachment partially mediated treatment effects | #8 |
Meditation awareness training (MAT) | neutral | sleep quality | Adults with FMS | - | non-attachment partially mediated treatment effects | #9 |
Meditation awareness training (MAT) | neutral | FMS symptomatology | Adults with FMS | - | non-attachment almost fully mediated treatment effects | #10 |
Meditation awareness training (MAT) | neutral | pain perception | Adults with FMS | - | non-attachment almost fully mediated treatment effects | #11 |
Average daily time spent in meditation | neutral | all outcome variables | Adults with FMS | - | was found to be a significant predictor of changes | #12 |
Meditation awareness training | decrease | FMS symptomatology | Adults with FMS | - | resulted in significant reductions | #13 |
OBJECTIVES: The purpose of this study was to conduct the first randomized controlled trial (RCT) to evaluate the effectiveness of a second-generation mindfulness-based intervention (SG-MBI) for treating fibromyalgia syndrome (FMS). Compared to first-generation mindfulness-based interventions, SG-MBIs are more acknowledging of the spiritual aspect of mindfulness. DESIGN: A RCT employing intent-to-treat analysis. METHODS: Adults with FMS received an 8-week SG-MBI known as meditation awareness training (MAT; n = 74) or an active control intervention known as cognitive behaviour theory for groups (n = 74). Assessments were performed at pre-, post-, and 6-month follow-up phases. RESULTS: Meditation awareness training participants demonstrated significant and sustained improvements over control group participants in FMS symptomatology, pain perception, sleep quality, psychological distress, non-attachment (to self, symptoms, and environment), and civic engagement. A mediation analysis found that (1) civic engagement partially mediated treatment effects for all outcome variables, (2) non-attachment partially mediated treatment effects for psychological distress and sleep quality, and (3) non-attachment almost fully mediated treatment effects for FMS symptomatology and pain perception. Average daily time spent in meditation was found to be a significant predictor of changes in all outcome variables. CONCLUSIONS: Meditation awareness training may be a suitable treatment for adults with FMS and appears to ameliorate FMS symptomatology and pain perception by reducing attachment to self. Statement of contribution What is already known on this subject? Designing interventions to treat fibromyalgia syndrome (FMS) continues to be a challenge. There is growing interest into the applications of mindfulness-based interventions for treating FMS. Second-generation mindfulness-based interventions (SG-MBIs) are a key new direction in mindfulness research. What does this study add? Meditation awareness training - an SG-MBI - resulted in significant reductions in FMS symptomatology. SG-MBIs recognize the spiritual aspect of mindfulness and may have a role in the treatment of FMS.